Get started
Author

Philip J. Rask

Observed name: Philip Rask
OpenAlex ID: A5075890849
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy‐mediated drug resistance in ovarian cancer cells, xenografts, and patient‐derived xenograft models
2019 · Janice M. Santiago‐O’Farrill, S. John Weroha, et al. · Cancer · 79
PDF
Long non‐coding RNAs differential expression in breast cancer subtypes: What do we know?
2019 · Carolina Mathias, Erika P. Zambalde, et al. · Clinical Genetics · 59
PDF
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
2022 · Zhen Lu, Weiqun Mao, et al. · Journal of Clinical Investigation · 46
Directed evolution of cyclic peptides for inhibition of autophagy
2021 · Joshua P. Gray, Md. Nasir Uddin, et al. · Chemical Science · 37
PDF
DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1
2019 · Margie N. Sutton, Gilbert Y. Huang, et al. · Cancers · 32
PDF
A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin
2021 · Dengxuan Fan, Hailing Yang, et al. · Cancers · 20
PDF
Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition
2020 · Alicia M. Blessing, Janice M. Santiago‐O'Farrill, et al. · Cancer · 16
Abstract 4768: PARP inhibitor-induced autophagy provides an adaptive mechanism of drug resistance in preclinical models of ovarian cancer
2019 · Janice M. Santiago-O'Farrill, Saravut J. Weroha, et al. · Cancer Research · 2
Abstract 5147: Identification of pharmacodynamic biomarkers in PBMCs and cancer cells for SIK2 kinase inhibitor therapy
2024 · Hailing Yang, Weiqun Mao, et al. · Cancer Research
Abstract 4263: Autophagic ovarian cancer cells exhibit substantially enhanced sensitivity to ALK inhibition
2019 · Alicia M. Blessing, Weiqun Mao, et al. · Molecular and Cellular Biology / Genetics
Abstract 4263: Autophagic ovarian cancer cells exhibit substantially enhanced sensitivity to ALK inhibition
2019 · Alicia M. Blessing, Weiqun Mao, et al. · Cancer Research
Abstract 4768: PARP inhibitor-induced autophagy provides an adaptive mechanism of drug resistance in preclinical models of ovarian cancer
2019 · Janice M. Santiago-O'Farrill, Saravut J. Weroha, et al. · Experimental and Molecular Therapeutics
Author response for "Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?"
2018 · Carolina Mathias, Erika P. Zambalde, et al.
Author response for "Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?"
2018 · Carolina Mathias, Erika P. Zambalde, et al.
Works count: 14
Citation count: 291
H-index: 7
I10-index: 7
Year
Topic
Type